Provided herein are compositions and kits including trichloroacetic acid, and methods of using the same for debridement during endodontic treatment.

The invention relates to dentistry, and more particularly to a novel agent in the form of a gel for the treatment and/or prophylaxis of conditions characterized by loss of minerals and salts front tooth enamel. The claimed agent, provided in gel foam, for the treatment and/or prophylaxis of conditions characterized by loss of minerals and salts from tooth enamel contains the following ingredients: 19 wt % glycerin, 10 wt % xylitol 2.3 wt % hydroxyethyl cellulose, 0.09 wt % guar gum, 1 5 wt % calcium glycerophosphate, 0.12 wt % magnesium chloride, 0.9 wt % non-ionic surfactant, 0.24 wt % preservative, 0.04 wt % flavouring agent, she remainder water. The claimed agent provides effective treatment and prophylaxis of the demineralization/hypomineralization of dental tissue, mild forms of fluorosis, and the adverse consequences thereof.

A dental device that provides for the entirely non-surgical management of early, cavitated dental lesions consisting of a ceramic wafer sized to cover the dental lesion and resin bonded to the tooth effectively encapsulating the dental lesion. The ceramic wafer may incorporate antimicrobial preparations, radiopaque markers, and/or silver diamine fluoride.

A dental device that provides for the entirely non-surgical management of early, cavitated dental lesions consisting of a ceramic wafer sized to cover the dental lesion and resin bonded to the tooth effectively encapsulating the dental lesion. The ceramic wafer may incorporate antimicrobial preparations, radiopaque markers, and/or silver diamine fluoride.

An oral varnish comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active ingredient, which is preferably a fluoride donor.

An oral varnish comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active ingredient, which is preferably a fluoride donor.

A pharmaceutical formulation for topical dental administration or medical (e.g., implant) treatment, including effective amounts of: at least one antimicrobial compound; at least one peroxide source compound; and at least one gel agent. Also disclosed are methods of oral anatomy treatment. The pharmaceutical formulation and treatment methods provide the patient with oral anatomy benefits including, for example, decreased or arrested gum recession; decreased or arrested bone recession; decreased or arrested bone mass loss; decreased or eliminated pain; decreased or eliminated bleeding; decreased or eliminated swelling; enhanced regeneration of bone; enhanced soft tissue repair; or a combination thereof.

A pharmaceutical formulation for topical dental administration or medical (e.g., implant) treatment, including effective amounts of: at least one antimicrobial compound; at least one peroxide source compound; and at least one gel agent. Also disclosed are methods of oral anatomy treatment. The pharmaceutical formulation and treatment methods provide the patient with oral anatomy benefits including, for example, decreased or arrested gum recession; decreased or arrested bone recession; decreased or arrested bone mass loss; decreased or eliminated pain; decreased or eliminated bleeding; decreased or eliminated swelling; enhanced regeneration of bone; enhanced soft tissue repair; or a combination thereof.

This patent application refers to oral health composition and preparation process thereof, suitable for direct administration into the oral cavity by specialists or otherwise, wherein the formulations have a wide action spectrum due to self-activation and continuous formation of reactive oxygen, with no need for external activation by light, chemicals or electricity, except for air oxygen, said oral health compositions acting through the synergistic action of air oxygen with octa-carboxy or tetra-carboxy (metal-phthalocyanines) being functional dyes capable of promoting self-activation and continuous production of reactive oxygen in the presence of molecular oxygen in suitable, safe and effective amounts over odor-making substances, microorganisms and over coagulation/healing mechanisms, among other properties of interest for maintenance of oral health, which may be used directly by the patient or by a professional.

An intraoral device, comprising an antiviral and/or antibacterial and/or antifungal ion releasing agent material(s) which, when said device is exposed to the oral cavity and to any gases, liquids and solids passing through the oral cavity, and is capable of inactivating viruses and/or bacteria and/or fungi penetrating into the oral cavity.